 recent pooled analysis of 1557 patients from
three large randomized trials (EVA-3S, SPACE, and ICSS)
showed an independent association between closed-cell
design and reduced risk of periprocedural stroke or
death.398 However, in a systemic review and comprehensive meta-analysis of 33 studies (including 2 randomized trials), use of an open cell stent design in CAS
was associated with decreased risk of restenosis
compared